Everything from molecular structure to freezer distribution involved ML, says tech chief
GTC AI algorithms were involved in every step of the way to design and deliver Pfizer's COVID-19 vaccine and antiviral tablets to hundreds of millions of people as coronavirus spread around the world.…
DUBLIN–(BUSINESS WIRE)–The “RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global RNA interference (RNAi) drug delivery market reached a value of US$ 54.74 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 184.98 Billion by […]
BERWYN, Pa.–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive product candidates for ... Read More
Gross Profit Percentage for the Quarter ended December 31, 2021 Increased 1% versus Prior Year and 8% versus Prior Quarter Net loss per Share of $(0.31) for the Third Quarter Compared to a Net Loss per Share of $(0.32) for the Prior Year $8.5 Million of Cash and Strengthened Balance Sheet WOODSTOCK, Ga.–(BUSINESS WIRE)–Sonoma Pharmaceuticals, […]
With new headlines out about how cannabis might be a weapon against covid-19, it seems our pharma loving world has managed to forget what has already been learned. When it comes to plant medicine and coronaviruses, we already know a good bit from previous research. The better question isn’t whether something like cannabis can help, […]
You’ve seen the headlines at this point, everyone has. It’s the new rage in covid-related discussions, and the talk at every party. That’s right, it finally broke that cannabis might be able to be used against covid-19, the pandemic that’s got everyone riled up. But shouldn’t we already know this? Why is this even news? […]
Chimeric antigen receptor (CAR) T cells have revolutionized cancer treatment. CARs use antibody-derived binding domains to redirect T cells to antigens expressed on the surface of cancer cells. However, the high affinity of most currently used CAR-binding domains results in excessive T-cell activation limiting CAR T-cell persistence and the inability to differentiate between antigen-high tumor cells and antigen-low healthy cells. We review recent data on the use of low-affinity CAR-binding domains and evaluate technologies and approaches to engineer and screen low-affinity antibody variants for CAR T-cell development.
Social media has been abuzz this week with news of a recently published laboratory study that found compounds in cannabis had the potential to stop COVID-19 from entering human cells. So does getting high increase immunity against COVID-19, or is it all too good to be true? The idea of using cannabis compounds to prevent or treat […]
